A Comparative Review of Waivers Granted in Pediatric Drug Development by FDA and EMA from 2007-2013

scientific article

A Comparative Review of Waivers Granted in Pediatric Drug Development by FDA and EMA from 2007-2013 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/2168479016646809
P932PMC publication ID4886500
P698PubMed publication ID27274951

P50authorPaolo TomasiQ39412896
P2093author name stringGerold T Wharton
Jean Temeck
M Dianne Murphy
Gunter F Egger
Suzanne Malli
P2860cites workAdvances in pediatric pharmacology, therapeutics, and toxicologyQ33998667
Fixed-dose combinations for treatment of type 2 diabetes mellitusQ37978206
Fixed combination of repaglinide and metformin in the management of type 2 diabetesQ42178891
P433issue5
P407language of work or nameEnglishQ1860
P304page(s)639-647
P577publication date2016-05-13
P1433published inDrug Information JournalQ5308855
P1476titleA Comparative Review of Waivers Granted in Pediatric Drug Development by FDA and EMA from 2007-2013
P478volume50

Reverse relations

cites work (P2860)
Q100533696Gap between pediatric and adult approvals of molecular targeted drugs
Q89949955Real-World Evidence to Assess Medication Safety or Effectiveness in Children: Systematic Review

Search more.